Senior Medical Science Liaison - Germany - North

The role

The Senior Medical Science Liaison serves as a scientific partner to healthcare professionals and researchers in Germany. This field-based role drives scientific exchange and supports evidence generation for rare pediatric diseases like Rett syndrome.

What you will do

• Act as the primary point of contact for scientific exchange in Germany
• Identify and maintain impactful collaborations including publications and advisory boards
• Support Key Account Managers in engaging influential experts
• Collect and communicate field insights to inform medical strategy
• Respond to unsolicited medical information requests
• Support Phase IV studies, IIS, registries, and real-world evidence projects
• Represent Acadia at congresses and scientific events
• Partner with Medical Affairs leadership to support patient advocacy initiatives
• Deliver internal medical training and scientific support to cross-functional teams
• Ensure medical governance in field activities

Required qualifications

• An advanced scientific or medical degree or a related field
• 6-8 years of relevant industry experience
• 3-5 years field-based MSL roles in CNS/neuroscience or rare disease
• Ability to present complex scientific data clearly and effectively
• Fluency in German and English
• Organizational skills
• Independent working style
• Fast learning mindset
• Collaborative approach
• Strong interpersonal skills

Nice to have

• MD or PhD
• PharmD

Benefits

• Competitive base, bonus, new hire and ongoing equity packages
• Medical, dental, and vision insurance
• Employer-paid life, disability, business travel and EAP coverage
• 401(k) Plan with a fully vested company match 1:1 up to 5%
• Employee Stock Purchase Plan with a 2-year purchase price lock-in
• 15+ vacation days
• 13 -15 paid holidays, including office closure between December 24th and January 1st
• 10 days of paid sick time
• Paid parental leave benefit
• Tuition assistance

About the company

Acadia is committed to turning scientific promise into meaningful innovation for underserved neurological and rare disease communities. Their portfolio includes treatments for Parkinson’s disease psychosis and Rett syndrome.